Ondansetron Metabolite E |
|
| Synonyms: 1,2,3,9-Tetrahydro-3-(1H-imidazol-1-ylmethyl)-9-methyl-4H-carbazol-4-one; EP Ondansetron Impurity G; C-desmethylondansetron | |
| Cat. No.: O65024 | CAS No.: 99614-03-6 |
| MDL.: | Formula: C17H17N3O |
| F.W.279.34 | Purity: 99％ |
| Storage: | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | O65024 | CAS No.: | 99614-03-6 | |
| MDL: | Formula: | C17H17N3O | ||
| F.W.: | 279.34 | Purity: | 99％ | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Reference: | Kris, M.G., et al.: J. Clin. Oncol., 6, 659 (1988), Faris, P..L., et al.: Lances, 355, 792 (2000), Ye, J.H., et al.: CNS Drug Reviews., 7, 199 (2001); | |||
| Application: | 1,2,3,9-Tetrahydro-3-(1H-imidazol-1-ylmethyl)-9-methyl-4H-carbazol-4-one is an metabolite of Ondansetron , is a selective 5-hydroxytryptamine3 (5-HT3) receptor antagonist that has been introduced to clinical practice as an antiemetic for cancer treatment- | |||
| Category: | Amines, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals | |||